Published in Biochim Biophys Acta on December 08, 1972
Alveolar response to experimental Pneumocystis carinii pneumonia in the rat. Am J Pathol (1980) 1.46
Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun (2004) 1.24
Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteins. Prostaglandins Leukot Essent Fatty Acids (2008) 1.02
The distribution of prostaglandins in afferent and efferent lymph from inflammatory sites. Am J Pathol (1980) 0.90
The effect of intravenous infusions of prostaglandins E-2 and F-2alpha on human gastric function. Gut (1975) 0.86
Antigen-induced non-specific suppressor factor in sheep efferent lymph is prostaglandin E2. Immunology (1981) 0.78
Binding of prostaglandin E2 to blood in man. Br J Clin Pharmacol (1975) 0.77
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature (1985) 6.86
Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest (1968) 3.52
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem (1990) 3.34
Influence of preoperative anxiety on hypotension after spinal anaesthesia in women undergoing Caesarean delivery. Br J Anaesth (2012) 3.29
Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins (1977) 2.48
Thromboxanes: selective biosynthesis and distinct biological properties. Science (1976) 2.46
Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res (1997) 2.22
Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci (1998) 2.17
Impact of community educational programmes on foreign body aspiration in Israel. Eur J Pediatr (1995) 2.09
Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci U S A (1979) 2.07
Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol (2000) 1.97
Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst (1995) 1.92
The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex. J Biol Chem (1969) 1.88
On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev (2001) 1.78
Studies on the protein-protein and protein-ligand interactions involved in retinol transport in plasma. J Biol Chem (1970) 1.68
Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. J Clin Invest (1977) 1.63
Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry (1994) 1.63
Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res (1999) 1.60
On the role of galectin-3 in cancer apoptosis. Apoptosis (2005) 1.60
Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets. Proc Natl Acad Sci U S A (1977) 1.56
Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res (2001) 1.55
The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res (1999) 1.51
Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes. Science (1977) 1.47
Galectin-3 stimulates cell proliferation. Exp Cell Res (1998) 1.44
Platelet and blood vessel arachidonate metabolism and interactions. J Clin Invest (1979) 1.44
Altered organization of cell-substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities. Cancer Res (1982) 1.41
Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res (1996) 1.41
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res (1996) 1.39
Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator. J Biol Chem (1977) 1.37
Interaction of prostaglandins with blood plasma proteins. Comparative binding of prostaglandins A 2 , F 2 and E 2 to human plasma proteins. Biochem J (1972) 1.32
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res (1982) 1.32
Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat. Am J Physiol (1977) 1.32
Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology (1998) 1.28
Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation. Biochem Biophys Res Commun (1989) 1.28
Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer (1995) 1.25
Selective incorporation of 14C-arachidonic acid into the phospholipids of intact tissues and subsequent metabolism to 14C-prostaglandins. Prostaglandins (1976) 1.24
Novel, selective delta6 or delta5 fatty acid desaturase inhibitors as antiinflammatory agents in mice. J Pharmacol Exp Ther (1998) 1.24
Radioimmunoassay of human plasma retinol-binding protein. J Clin Invest (1970) 1.24
Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res (1980) 1.23
Speech sounds learned by sleeping newborns. Nature (2002) 1.23
Lectin-like activities associated with human and murine neoplastic cells. Cancer Res (1981) 1.23
Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj J (1994) 1.21
The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. FEBS Lett (1999) 1.21
Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr (2001) 1.20
Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis. Am J Pathol (2001) 1.19
Motility and adhesive properties of high- and low-metastatic murine neoplastic cells. Cancer Res (1984) 1.19
Aspirated foreign bodies in the respiratory tract of children: eleven years experience with 127 patients. Int J Pediatr Otorhinolaryngol (1994) 1.19
Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells. Cancer Res (1998) 1.19
Bradykinin and angiotensin II activation of arachidonic acid deacylation and prostaglandin E2 formation in rabbit kidney. Hormone-sensitive versus hormone-insensitive lipid pools of arachidonic acid. J Biol Chem (1981) 1.18
A novel prostaglandin is the major product of arachidonic acid metabolism in rabbit heart. Proc Natl Acad Sci U S A (1977) 1.15
Morphological study of fully and partially isolated early human follicles. Fertil Steril (2001) 1.13
Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res (1990) 1.13
Hormonal stimulation of arachidonate release from isolated perfused organs. Relationship to prostaglandin biosynthesis. Prostaglandins (1977) 1.13
Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem (1991) 1.12
Endoperoxides and thromboxanes. Structural determinants for platelet aggregation and vasoconstriction. Biochim Biophys Acta (1977) 1.11
Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res (1981) 1.11
Multinucleation and inhibition of cytokinesis in suspended cells: reversal upon reattachment to a substrate. Cell (1981) 1.10
Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Int J Oncol (2001) 1.09
Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res (1995) 1.08
Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-line. Int J Oncol (1995) 1.07
Decreased galectin-3 expression in prostate cancer. Prostate (2000) 1.07
Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res (1994) 1.06
Electrospray/tandem mass spectrometry for quantitative analysis of lipid remodeling in essential fatty acid deficient mice. Anal Biochem (2000) 1.05
Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. J Comp Neurol (1992) 1.05
Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein. Biochim Biophys Acta (2000) 1.04
Cell surface properties of B16 melanoma variants with differing metastatic potential. Cancer Res (1980) 1.04
Lectins in cancer cells. Ann N Y Acad Sci (1988) 1.03
Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Res Treat (1998) 1.03
Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer (1999) 1.02
Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment. Cell Death Dis (2010) 1.02
Purinergic vs peptidergic stimulation of lipolysis and prostaglandin generation in the perfused rabbit kidney. Biochem Pharmacol (1982) 1.02
Structure-function relationship of a recombinant human galactoside-binding protein. Biochemistry (1993) 1.02
Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res (1996) 1.01
Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J Natl Cancer Inst (1992) 1.01
Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invasion Metastasis (1997) 1.01
Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer (2002) 1.01
Differential expression of cell adhesion molecules in variants of K1735 melanoma cells differing in metastatic capacity. Int J Cancer (1989) 1.00
Cell configuration and adhesive properties of metastasizing and non-metastasizing BSp73 rat adenocarcinoma cells. Exp Cell Res (1986) 0.99
Purification of B16-F1 melanoma autocrine motility factor and its receptor. Cancer Res (1991) 0.99
Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential. Nature (1980) 0.99
Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem (2000) 0.98
Physiology of MPTP tremor. Mov Disord (1998) 0.97
Effects of bivalent cations on prostaglandin biosynthesis and phospholipase A2 activation in rabbit kidney medulla slices. Biochem J (1979) 0.97
Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells. Invasion Metastasis (1991) 0.97
Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy. Endocr Relat Cancer (2004) 0.97
Cell shape modulation alters glycosylation of a metastatic melanoma cell-surface antigen. Int J Cancer (1987) 0.96
Concanavalin A and the in vitro induction in macrophages of vacuolation and lysosomal enzyme synthesis. Exp Cell Res (1975) 0.96
Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res (2000) 0.96
Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility. Biochem Biophys Res Commun (2001) 0.96
Evidence for different purinergic receptors for ATP and ADP in rabbit kidney and heart. Eur J Pharmacol (1981) 0.95
Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer (1994) 0.95
Autocrine motility factor and its receptor: role in cell locomotion and metastasis. Cancer Metastasis Rev (1992) 0.94
Transformation-related changes in the expression of endogenous cell lectins. Int J Cancer (1987) 0.94
Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization. Cancer Res (1986) 0.94
Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE. Int J Cancer (1993) 0.94
Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer (1997) 0.93
Differential expression of intermediate filament proteins in metastatic and nonmetastatic variants of the BSp73 tumor. Cancer Res (1986) 0.93
Prostaglandin generation in rabbit kidney. Hormone-activated selective lipolysis coupled to prostaglandin biosynthesis. Biochim Biophys Acta (1979) 0.93
Antibodies to ganglioside GM1 induce mitogenic stimulation and cap formation in rat thymocytes. Eur J Immunol (1978) 0.92
Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation. Cancer Res (1983) 0.92